All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Cancer genomics specialist Inivata Ltd. and Gustave Roussy have reported positive results from a study using the Invision liquid biopsy platform to guide treatment for lung cancer based on circulating tumor DNA (ctDNA) results in a real-world setting.